Formulation: A solid
Formal Name: N-((2S,3R,4R,5R,6R)-2-(((2R,3R,4S,5S,6R)-2-(((2R,3R,4R,5R,6S)-6-(((2R,3S,4R,5R,6R)-6-(((2S,3R,E)-2-amino-3-hydroxyoctadec-4-en-1-yl)oxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide
Purity: ≥98%
Formula Markup: C44H80N2O22
Formula Weight: 989,1
Shelf life (days): 730
Notes: Lyso-globotetraosylceramide is a form of globotetraosylceramide (Gb4) lacking the fatty acyl group. It binds to the Shiga-like toxin pig verotoxin of edema disease (VTE) in a glycolipid binding assay.{45542} Lyso-globotetraosylceramide is acylated to stearic acid (Item No. 10011298) via a condensation reaction mediated by sphingolipid ceramide N-deacylase to form a ceramide.{45543} As this product is derived from a natural source, there may be variations in the sphingoid backbone. [Matreya, LLC. Catalog No. 1541]
English
Deutsch
